(Q33813139)

29 July 2017

1 reference

title

Development, disease and degeneration in schizophrenia: a unitary pathophysiological model (English)

1 reference

29 July 2017

0 references

1 reference

Keshavan MS

1

1 reference

29 July 2017

1 November 1999

1 reference

Journal of Psychiatric Research

29 July 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 July 2017

33

1 reference

29 July 2017

6

1 reference

29 July 2017

513-521

1 reference

Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Oxidative stress induced by glutamate receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Structural brain abnormalities as indicators of vulnerability to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Positron emission tomography study of human brain functional development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Selective vulnerability of brain: new insights from the excitatory synapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

The glutamatergic dysfunction hypothesis for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

The neuropsychology of schizophrenia: A perspective from neurobehavioral genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Is schizophrenia a lifetime disorder of brain plasticity, growth and aging?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

A summary of attentional findings in the New York High-Risk Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

The effects of stress on central dopaminergic neurons: possible clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Infant predictors of the longitudinal course of schizophrenic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Premorbid and onset features of first-episode schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

The Influence of Age and Sex on the Onset and Early Course of Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

The NMDA receptor subunit NR2B of neonatal rat brain: complex formation and enrichment in axonal growth cones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Synaptic elimination, neurodevelopment, and the mechanism of hallucinated "voices" in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Late childhood changes in brain morphology observable with MRI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Neuronal death in development, aging, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Neurotransmitters and vulnerability of the developing brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

The new epidemiology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

DNQX blockade of amphetamine behavioral sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Modulation of neuronal migration by NMDA receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Cortical dopamine in schizophrenia: strategies for postmortem studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Duration of psychosis and outcome in first-episode schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Chemical and physiologic brain imaging in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Physiological and pathophysiological roles of excitatory amino acids during central nervous system development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Subtype progression and pathophysiologic deterioration in early schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Is schizophrenia a neurodevelopmental disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Malformations of the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Persistent increase in dopamine release following activation of metabotropic glutamate receptors in the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Involvement of the N-methyl D-aspartate (NMDA) receptor in synapse elimination during cerebellar development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

A linkage study of the N-methyl-D-aspartate receptor subunit gene loci and schizophrenia in southern African Bantu-speaking families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Patterns of Childhood Social Development in Adult Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Implications of normal brain development for the pathogenesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

From neuropathology to neurodevelopment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Glutamatergic control over brain dopamine release in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Schizophrenia, just the facts. What do we know, how well do we know it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Neuroleptics and the Natural Course of Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Changes in synaptic density in motor cortex of rhesus monkey during fetal and postnatal life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

Widespread cerebral gray matter volume deficits in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900033-3

10.1016/S0022-3956(99)00033-3

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10628528